-
公开(公告)号:US20140135332A1
公开(公告)日:2014-05-15
申请号:US14112735
申请日:2012-04-20
申请人: David John Haydon , Lloyd George Czaplewski , Neil Robert Stokes , David Davies , Ian Collins , James T Palmer , Jeffrey Peter Mitchell , Gary Robert William Pitt , Daniel Offermann
发明人: David John Haydon , Lloyd George Czaplewski , Neil Robert Stokes , David Davies , Ian Collins , James T Palmer , Jeffrey Peter Mitchell , Gary Robert William Pitt , Daniel Offermann
IPC分类号: A61K31/5377 , A61K31/506 , A61K31/437 , A61K31/4439 , A61K31/433 , A61K31/427 , A61K31/421 , C07D513/04 , C07D413/12 , C07D285/08 , C07D277/30 , C07D263/32 , A61K31/496 , A61K31/426
CPC分类号: A61K31/5377 , A61K31/166 , A61K31/421 , A61K31/4245 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/437 , A61K31/4439 , A61K31/496 , A61K31/506 , C07D263/32 , C07D271/06 , C07D277/24 , C07D277/30 , C07D285/08 , C07D413/06 , C07D413/10 , C07D413/12 , C07D417/06 , C07D417/12 , C07D513/04
摘要: The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.
摘要翻译: 本发明提供式(I)的化合物:及其盐,外消旋物,异构体,非对映异构体,对映异构体,水合物,溶剂化物,N-氧化物,其药学上可接受的衍生物或前药。 还提供这些化合物作为抗菌剂的用途,包含它们的组合物及其制备方法。
-
公开(公告)号:US08415383B2
公开(公告)日:2013-04-09
申请号:US12679334
申请日:2008-09-22
CPC分类号: C07D277/34 , A61K31/4245 , A61K31/427 , A61K31/429 , A61K31/433 , C07D271/07 , C07D277/64 , C07D285/08 , C07D417/12
摘要: Compounds of formula (IA) or (IB) have antibacterial activity: wherein W is ═C(H)— or ═N—; R3 is a radical of formula -(Alk1)m-(Z1)p-(Alk2)n-Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1, Z1 is —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, —N(CH2CH3)—, —C(—O)—, —0—(C═O)—, —C(═O)—O—, or an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted divalent bicyclic carbocyclic or heterocyclic radical having 5 to 10 ring atoms; Alk1 and Alk2 are optionally substituted C1-C6 alkylene, C2-C6 alkenylene, or C2-C6 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, Or —N(CH2CH3)—; and Q is hydrogen, halogen, nitrile, or hydroxyl, or an optionally substituted monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted bicyclic carbocyclic or heterocyclic radical having 5 to 10 ring atoms; R4 and R5 are optional substituents; and R2, R6 and R7 are independently hydrogen or a radical of formula -(Alk3)x-(Z2)y-(Alk4)z-H wherein x, y and z are independently 0 or 1, Z2 is —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, —N(CH2CH3)—, —C(—O)—, —0—(C═O)— or —C(═O)—O—; Alk3 and Alk4 are optionally substituted C1-C3 alkylene, C2-C3 alkenylene, or C2-C3 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, or —N(CH2CH3)—.
-
公开(公告)号:US20100173933A1
公开(公告)日:2010-07-08
申请号:US12293608
申请日:2007-03-22
IPC分类号: A61K31/437 , C07D277/62 , C07D471/04 , C07D263/34 , C07D271/06 , A61K31/428 , A61K31/421 , A61K31/41 , A61P31/04
CPC分类号: C07C235/46 , A01N37/40 , A01N41/04 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/42 , A01N43/76 , A01N43/78 , A01N43/82 , A01N43/90 , A61K31/166 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/381 , A61K31/4025 , A61K31/4155 , A61K31/4178 , A61K31/4184 , A61K31/4192 , A61K31/4196 , A61K31/422 , A61K31/423 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/429 , A61K31/433 , A61K31/44 , A61K31/4422 , A61K31/4523 , A61K31/4709 , C07C255/16 , C07C309/73 , C07C2601/02 , C07C2601/14 , C07C2601/18 , C07D213/30 , C07D213/81 , C07D215/12 , C07D215/14 , C07D231/12 , C07D233/64 , C07D249/04 , C07D261/08 , C07D263/32 , C07D263/56 , C07D271/06 , C07D271/10 , C07D277/24 , C07D277/32 , C07D277/64 , C07D307/42 , C07D307/56 , C07D319/20 , C07D333/06 , C07D333/12 , C07D333/16 , C07D333/56 , C07D413/04 , C07D417/04 , C07D417/06 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
摘要: Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R1)— or ═N—; R1 is hydrogen or an optional substituent and R2 is hydrogen, methyl, or fluorine; or R1 and R2 taken together are —CH2—, —CH2CH2—, —O—, or, in either orientation, —O—CH2— or —OCH2CH2—; R3 is a radical of formula -(Alk1)m-(Z)p-(Alk2)n-Q wherein m, p and n are independently 0 or 1, provided that at least one of m, p and n is 1, Z is —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, —N(CH2CH3)—, —C(═O)—, —O—(C═O)—, —C(═O)—O—, or an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted divalent bicyclic heterocyclic radical having 5 to 10 ring atoms; Alk1 and Alk2 are optionally substituted C1-C6 alkylene, C2-C6 alkenylene, or C2-C6 alkynylene radicals, which may optionally terminate with or be interrupted by —O—, —S—, —S(O)—, —S(O2)—, —NH—, —N(CH3)—, or —N(CH2CH3)—; and Q is hydrogen, halogen, nitrile, or hydroxyl or an optionally substituted monocyclic carbocyclic or heterocyclic radical having 3 to 6 ring atoms; or an optionally substituted bicyclic heterocyclic radical having 5 to 10 ring atoms.
摘要翻译: 式(I)化合物具有抗菌活性:其中R表示氢或1,2或3个任选的取代基; W是≡C(R1) - 或=N-; R1是氢或任选的取代基,R 2是氢,甲基或氟; 或R 1和R 2一起为-CH 2 - , - CH 2 CH 2 - , - O-,或者在任一取向为-O-CH 2 - 或-OCH 2 CH 2 - ; R3是式 - (Alk1)m-(Z)p-(Alk2)nQ的基团,其中m,p和n独立地为0或1,条件是m,p和n中的至少一个为1,Z为 - (O) - , - S(O 2) - , - NH - , - N(CH 3) - , - N(CH 2 CH 3) - , - (C = O) - , - C(= O)-O-,或具有3至6个环原子的任选取代的二价单环碳环或杂环基; 或具有5至10个环原子的任选取代的二价双环杂环基; Alk1和Alk2是任选取代的C 1 -C 6亚烷基,C 2 -C 6亚烯基或C 2 -C 6亚炔基,其可以任选地被-O - , - S - , - S(O) - , - S( O,-N(CH 3) - 或-N(CH 2 CH 3) - ; 和Q是氢,卤素,腈或羟基或任选取代的具有3-6个环原子的单环碳环或杂环基; 或具有5〜10个环原子的任意取代的双环杂环基。
-
公开(公告)号:US08865736B2
公开(公告)日:2014-10-21
申请号:US13304748
申请日:2011-11-28
IPC分类号: A01N43/44 , A61K31/352 , A61K31/381 , A61K31/4192 , A61K31/422 , C07D261/08 , C07D277/24 , A61K31/341 , A61K31/4523 , A61K31/343 , A61K31/428 , C07D413/04 , C07D277/64 , C07D263/56 , A61K31/4178 , C07D231/12 , A61K31/4245 , A61K31/4709 , A61K31/166 , C07D498/04 , C07D471/04 , C07D417/14 , C07D307/42 , C07D213/30 , C07D333/12 , A61K31/4184 , A61K31/433 , C07D417/06 , A61K31/4422 , A61K31/44 , C07D271/10 , C07D215/12 , C07D417/04 , C07D319/20 , A61K31/4155 , C07D513/04 , C07D263/32 , C07D249/04 , C07D233/64 , C07D333/06 , A61K31/4196 , C07D213/81 , C07D333/56 , A61K31/429 , C07D277/32 , C07D271/06 , A61K31/423 , A61K31/4025 , A61K31/427
CPC分类号: C07C235/46 , A01N37/40 , A01N41/04 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/42 , A01N43/76 , A01N43/78 , A01N43/82 , A01N43/90 , A61K31/166 , A61K31/341 , A61K31/343 , A61K31/352 , A61K31/381 , A61K31/4025 , A61K31/4155 , A61K31/4178 , A61K31/4184 , A61K31/4192 , A61K31/4196 , A61K31/422 , A61K31/423 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/429 , A61K31/433 , A61K31/44 , A61K31/4422 , A61K31/4523 , A61K31/4709 , C07C255/16 , C07C309/73 , C07C2601/02 , C07C2601/14 , C07C2601/18 , C07D213/30 , C07D213/81 , C07D215/12 , C07D215/14 , C07D231/12 , C07D233/64 , C07D249/04 , C07D261/08 , C07D263/32 , C07D263/56 , C07D271/06 , C07D271/10 , C07D277/24 , C07D277/32 , C07D277/64 , C07D307/42 , C07D307/56 , C07D319/20 , C07D333/06 , C07D333/12 , C07D333/16 , C07D333/56 , C07D413/04 , C07D417/04 , C07D417/06 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
摘要: Compounds of formula (I) have antibacterial activity: wherein R represents hydrogen or 1, 2 or 3 optional substituents; W is ═C(R1)—; R1 is hydrogen and R2 is hydrogen, methyl, or fluorine; or R1 and R2 taken together are —CH2—, —CH2CH2, —O—, or, in either orientation, —O—CH2— or —OCH2CH2—; and R3 is a radical of formula -(Alk1)m-(Z)p-(Alk2)n-Q.
摘要翻译: 式(I)化合物具有抗菌活性:其中R表示氢或1,2或3个任选的取代基; W为═C(R1) - ; R1是氢,R2是氢,甲基或氟; 或R 1和R 2一起为-CH 2 - , - CH 2 CH 2,-O-,或者在任一取向为-O-CH 2 - 或-OCH 2 CH 2 - ; 并且R3是式 - (Alk1)m-(Z)p-(Alk2)n-Q的基团。
-
公开(公告)号:US20100311766A1
公开(公告)日:2010-12-09
申请号:US12747753
申请日:2008-12-12
IPC分类号: A61K31/497 , C07D513/04 , A61K31/444 , A61P31/04 , A01N43/40 , A01N43/60 , A01P1/00
CPC分类号: C07D513/04
摘要: Compounds of formula (I) have antibacterial activity wherein: m is O or 1; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C3 alkylene, C2-C3 alkenylene or C2-C3 alkynylene radical; X is —C(═O)NH— or —C(═O)O—; R2 and R3 are as defined in the specification.
摘要翻译: 式(I)化合物具有抗菌活性,其中:m为0或1; Q是氢或环丙基; Alk是任选取代的二价C 1 -C 3亚烷基,C 2 -C 3亚烯基或C 2 -C 3亚炔基; X是-C(= O)NH-或-C(= O)O-; R2和R3如说明书中所定义。
-
公开(公告)号:US20100305067A1
公开(公告)日:2010-12-02
申请号:US12747811
申请日:2008-12-12
IPC分类号: A61K31/4439 , C07D417/10 , C07D417/14 , A01N43/40 , A61K31/437 , A01N43/90 , A61K31/5383 , A61K31/69 , A01N55/08 , A61P31/04 , A01P1/00
CPC分类号: C07D417/04 , C07D277/82 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
摘要: Compound of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, or —C(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl; Z1 is —N═ or —CH═Z2 is —N═ or —C(R1)═; R1 is hydrogen, methyl, ethyl, ethenyl, ethynyl, methoxy, mercapto, mercaptomethyl, halo, fully or partially fluorinated (C1-C2)alkyl, (C1-C2Jalkoxy or (C1-C2)alkylthio, nitro, or nitrile (—CN); R2 is a group Q1-[Alk1]q-Q2-, wherein q is 0 or 1; AIk1 is an optionally substituted, divalent, straight chain or branched C1-C6 alkylene, or C2-C6 alkenylene or C2-C6 alkynylene radical which may contain or terminate in an ether (—O—), thioether (—S—) or amino (—NR)— link; Q2 is an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 5 or 6 ring atoms or an optionally substituted divalent bicyclic carbocyclic or heterocyclic radical having 9 or 10 ring atoms; Q1 is hydrogen, an optional substituent, or an optionally substituted carbocyclic or heterocyclic radical having 3-7 ring atoms.
摘要翻译: 式(I)化合物具有抗菌活性:其中:m为0或1; Q是氢或环丙基; Alk是可以含有醚(-O-),硫醚(-S-)或氨基(-NR) - 连接的任意取代的二价C 1 -C 6亚烷基,亚烯基或亚炔基,其中R是氢,-CN或 C1-C3烷基; X是-C(= O)NR 6 - 或-C(= O)O-,其中R 6是氢,任选取代的C 1 -C 6烷基,C 2 -C 6烯基或C 2 -C 6炔基; Z1是-N =或-CH = Z2是-N =或-C(R1)=; R 1是氢,甲基,乙基,乙烯基,乙炔基,甲氧基,巯基,巯基甲基,卤素,完全或部分氟化的(C1-C2)烷基,(C1-C2烷氧基或(C1-C2)烷硫基,硝基或腈 ); R2是Q1- [Alk1] q-Q2-,其中q是0或1; Alk1是任选取代的,二价的,直链或支链的C 1 -C 6亚烷基或C 2 -C 6亚烯基或C 2 -C 6亚炔基 可以含有或终止于醚(-O-),硫醚(-S-)或氨基(-NR))连接基团的基团; Q 2是具有5或6个环原子的任选取代的二价单环碳环或杂环基团, 具有9或10个环原子的取代的二价双环碳环或杂环基; Q 1是氢,任选的取代基或具有3-7个环原子的任选取代的碳环或杂环基。
-
公开(公告)号:US08389516B2
公开(公告)日:2013-03-05
申请号:US13154592
申请日:2011-06-07
申请人: David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人: David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号: A61K31/5377 , A61K31/501 , A61K31/497 , A61K31/496 , A61K31/506 , A61K31/4436 , A61K31/428 , A61K31/429 , C07D239/42
CPC分类号: C07D417/04 , C07D417/14 , Y02P20/582
摘要: Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; Alk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N or CH, or CF; R2 and R3 are as defined in the description.
摘要翻译: 式(I)化合物具有抗菌活性:其中:m为0或1; Q是氢或环丙基; Alk是可以含有醚(-O-),硫醚(-S-)或氨基(-NR) - 连接的任意取代的二价C1-C6亚烷基,亚烯基或亚炔基,其中R是氢,-CN或 C1-C3烷基; X是-C(= O)NR 6 - , - S(O)NR 6 - , - C(= O)O-或-S(= O)O-,其中R 6是氢,任选取代的C 1 -C 6烷基, C6链烯基,C2-C6炔基,-Cyc或 - (C1-C3烷基)-Cyc,其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N或CH,或CF; R2和R3如说明书中所定义。
-
公开(公告)号:US08299065B2
公开(公告)日:2012-10-30
申请号:US12747811
申请日:2008-12-12
IPC分类号: A61K31/5365 , A61K31/4427 , A61K31/4196 , A61K31/497 , A61K31/428 , A61K31/47 , A61K31/5377 , A61K31/506 , C07D417/14 , C07D417/02 , C07D265/28 , C07D241/10 , C07D277/62 , C07D401/14 , C07D265/30 , C07D241/04 , C07D239/20
CPC分类号: C07D417/04 , C07D277/82 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
摘要: Compound of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, or —C(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl; Z1 is —N═ or —CH═Z2 is —N═ or —C(R1)═; R1 is hydrogen, methyl, ethyl, ethenyl, ethynyl, methoxy, mercapto, mercaptomethyl, halo, fully or partially fluorinated (C1-C2)alkyl, (C1-C2JaIkoxy or (C1-C2)alkylthio, nitro, or nitrile (—CN); R2 is a group Q1-[Alk1]q-Q2-, wherein q is 0 or 1; AIk1 is an optionally substituted, divalent, straight chain or branched C1-C6 alkylene, or C2-C6 alkenylene or C2-C6 alkynylene radical which may contain or terminate in an ether (—O—), thioether (—S—) or amino (—NR)— link; Q2 is an optionally substituted divalent monocyclic carbocyclic or heterocyclic radical having 5 or 6 ring atoms or an optionally substituted divalent bicyclic carbocyclic or heterocyclic radical having 9 or 10 ring atoms; Q1 is hydrogen, an optional substituent, or an optionally substituted carbocyclic or heterocyclic radical having 3-7 ring atoms.
摘要翻译: 式(I)化合物具有抗菌活性:其中:m为0或1; Q是氢或环丙基; Alk是可以含有醚(-O-),硫醚(-S-)或氨基(-NR) - 连接的任意取代的二价C 1 -C 6亚烷基,亚烯基或亚炔基,其中R是氢,-CN或 C1-C3烷基; X是-C(= O)NR 6 - 或-C(= O)O-,其中R 6是氢,任选取代的C 1 -C 6烷基,C 2 -C 6烯基或C 2 -C 6炔基; Z1是-N =或-CH = Z2是-N =或-C(R1)=; R 1是氢,甲基,乙基,乙烯基,乙炔基,甲氧基,巯基,巯基甲基,卤素,完全或部分氟化的(C1-C2)烷基,(C1-C2-烷氧基或(C1-C2)烷硫基,硝基或腈 ); R2是Q1- [Alk1] q-Q2-,其中q是0或1; Alk1是任选取代的,二价的,直链或支链的C 1 -C 6亚烷基或C 2 -C 6亚烯基或C 2 -C 6亚炔基 可以含有或终止于醚(-O-),硫醚(-S-)或氨基(-NR))连接基团的基团; Q 2是具有5或6个环原子的任选取代的二价单环碳环或杂环基团, 具有9或10个环原子的取代的二价双环碳环或杂环基; Q 1是氢,任选的取代基或具有3-7个环原子的任选取代的碳环或杂环基。
-
公开(公告)号:US07977340B2
公开(公告)日:2011-07-12
申请号:US12304303
申请日:2007-06-21
申请人: David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
发明人: David John Haydon , Lloyd George Czaplewski , Nicholas John Palmer , Dale Robert Mitchell , John Frederick Atherall , Christopher Richard Steele , Tamara Ladduwahetty
IPC分类号: A61K31/4412 , A61K31/4436 , A61K31/497 , A61K31/506 , C07D403/14 , C07D417/14
CPC分类号: C07D417/04 , C07D417/14 , Y02P20/582
摘要: Compounds of formula (I) have antibacterial activity: wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; AIk is an optionally substituted, divalent C1-C6 alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C1-C3 alkyl; X is —C(═O)NR6—, —S(O)NR6—, —C(═O)O— or —S(═O)O— wherein R6 is hydrogen, optionally substituted C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, -Cyc, or —(C1-C3 alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N or CH, or CF; R2 and R3 are as defined in the description.
摘要翻译: 式(I)化合物具有抗菌活性:其中:m为0或1; Q是氢或环丙基; Alk是可以含有醚(-O-),硫醚(-S-)或氨基(-NR) - 连接的任意取代的二价C 1 -C 6亚烷基,亚烯基或亚炔基,其中R是氢,-CN或 C1-C3烷基; X是-C(= O)NR 6 - , - S(O)NR 6 - , - C(= O)O-或-S(= O)O-,其中R 6是氢,任选取代的C 1 -C 6烷基, C6链烯基,C2-C6炔基,-Cyc或 - (C1-C3烷基)-Cyc,其中Cyc是具有3-7个环原子的任选取代的单环碳环或杂环; Z是N或CH,或CF; R2和R3如说明书中所定义。
-
公开(公告)号:US09511073B2
公开(公告)日:2016-12-06
申请号:US14112735
申请日:2012-04-20
申请人: David John Haydon , Lloyd George Czaplewski , Neil Robert Stokes , David Davies , Ian Collins , James T. Palmer , Jeffrey Peter Mitchell , Gary Robert William Pitt , Daniel Offermann
发明人: David John Haydon , Lloyd George Czaplewski , Neil Robert Stokes , David Davies , Ian Collins , James T. Palmer , Jeffrey Peter Mitchell , Gary Robert William Pitt , Daniel Offermann
IPC分类号: C07D263/32 , C07D417/06 , C07D413/06 , C07D277/24 , C07D417/12 , C07D413/12 , C07D285/08 , C07D513/04 , C07D413/10 , C07D271/06 , A61K31/5377 , A61K31/166 , A61K31/4245 , A61K31/421 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/437 , A61K31/4439 , A61K31/496 , A61K31/506 , C07D277/30
CPC分类号: A61K31/5377 , A61K31/166 , A61K31/421 , A61K31/4245 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/437 , A61K31/4439 , A61K31/496 , A61K31/506 , C07D263/32 , C07D271/06 , C07D277/24 , C07D277/30 , C07D285/08 , C07D413/06 , C07D413/10 , C07D413/12 , C07D417/06 , C07D417/12 , C07D513/04
摘要: The present invention provides compounds of Formula (I): and salts, racemates, isomers, diastereoisomers, enantiomers, hydrates, solvates, N-oxides, pharmaceutically acceptable derivatives or prodrugs thereof. Also provided the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.
-
-
-
-
-
-
-
-
-